Evaluation of eight preservation solutions for endothelial in situ preservation

Transplantation

Volumn 78, Issue 7, 2004, Pages 1008-1013

  Wilson, Colin H ^a,b,c   Stansby, Gerard ^a,c   Haswell, Malcolm ^b   Cunningham, Anne C ^b   Talbot, David ^a,c  

^a FREEMAN HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SUNDERLAND   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Endothelium; Preservation solutions; Transplantation; Warm ischemia

Indexed keywords

ACETYLCHOLINE; BELZER MPS SOLUTION; CELSIOR; CITRIC ACID; HTK SOLUTION; KPS 1; MARSHALL SOLUTION; NITRIC OXIDE; PBS14 SOLUTION; PERFADEX; PERFADEX SOLUTION; PRESERVATIVE; SOLTRAN; STARCH; UNCLASSIFIED DRUG; UNIVERSITY OF WISCONSIN SOLUTION; UW HES SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL PROTOCOL; COLD ISCHEMIA; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM; ENDOTHELIUM INJURY; FLOW RATE; HYPOTHERMIC MACHINE PRESERVATION; IMPLANTATION; IN SITU PRESERVATION; ISCHEMIA; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; NON HEART BEATING DONOR; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SMOOTH MUSCLE CONTRACTION; STRUCTURE ACTIVITY RELATION; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR TISSUE; VASODILATATION;

ADENOSINE; ALLOPURINOL; ANIMALS; ENDOTHELIUM, VASCULAR; GLUTATHIONE; INSULIN; MALE; MODELS, ANIMAL; ORGAN PRESERVATION SOLUTIONS; RAFFINOSE; RATS; RATS, INBRED LEW; TISSUE PRESERVATION;

EID: 6344245656     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000135465.00738.ED     Document Type: Article

References (29)

1. Gok MA, Buckley PE, Shenton BK, et al. Long-term renal function in kidneys from non-heart-beating donors: A single-center experience. Transplantation 2002; 74: 664.
2. Brook NR, White SA, Waller JR, et al. Non-heart beating donor kidneys with delayed graft function have superior graft survival compared with conventional heart-beating donor kidneys that develop delayed graft function. Am J Transplant 2003; 3: 614.
3. Ploeg RJ, Niesing J, Sieber-Rasch MH, et al. Shortage of donation despite an adequate number of donors: A professional attitude? Transplantation 2003; 76: 948.
4. Daemen JW, Oomen AP, Kelders WP, et al. The potential pool of non-heart-beating kidney donors. Clin Transplant 1997; 11: 149.
5. Yamauchi JI, Richter S, Vollmar B, et al. Warm preflush with streptokinase improves microvascular procurement and tissue integrity in liver graft retrieval from non-heart-beating donors. Transplantation 2000; 69: 1780.
6. Brasile L, Stubenitsky BM, Booster MH, et al. Overcoming severe renal ischemia: The role of ex vivo warm perfusion. Transplantation 2002; 73: 897.
7. Imber CJ, St Peter SD, Lopez de Cenarruzabeitia I, et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation 2002; 73: 701.
8. Brook NR, Waller JR, Nicholson ML. Nonheart-beating kidney donation: Current practice and future developments. Kidney Int 2003; 63: 1516.
9. Wilson CH, Shenton BK, Balupuri S, et al. Weight increase during machine perfusion may be an indicator of organ and, in particular, vascular damage. Ann Transplant 2004; 9: 30.
10. Bell P, Dibekoglu M, Gonzalez C, et al. Results of transplantation with non-heart-beating donors. Transplant Proc 1995; 27: 2951.
11. Heineman E, Daemen JH, Kootstra G. Non-heart-beating donors: Methods and techniques. Transplant Proc 1995; 27: 2895.
12. Hayry P. Chronic rejection: An update on the mechanism. Transplant Proc 1998; 30: 3993.
13. Land W, Schneeberger H, Schleibner S, et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211.
14. Gourishankar S, Halloran PF. Late deterioration of organ transplants: A problem in injury and homeostasis. Curr Opin Immunol 2002; 14: 576.
15. Valantine HA. Cardiac allograft vasculopathy: Central role of endothelial injury leading to transplant "atheroma". Transplantation 2003; 76: 891.
16. Corner JA, Berwanger CS, Stansby G. Preservation of vascular tissue under hypothermic conditions. J Surg Res 2003; 113: 21.
17. Berwanger CS, Cleanthis TM, Hafez HM, et al. Deuterium oxide-based University of Wisconsin solution improves viability of hypothermically stored vascular tissue. Transplantation 1998; 65: 735.
18. Frost-Arner L, Bergqvist D. Effect of isovolemic hemodilution with dextran and albumin on thrombus formation in artificial vessel grafts inserted into the abdominal aorta of the rabbit. Microsurgery 1995; 16: 357.
19. Muller C, Furst H, Reichenspurner H, et al. Lung procurement by low-potassium dextran and the effect on preservation injury. Munich Lung Transplant Group. Transplantation 1999; 68: 1139.
20. Gardiner SM, Compton AM, Bennett T, et al. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 1990; 15: 486.
21. Rees DD, Palmer RM, Schulz R, et al. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101: 746.
22. Booster MH, van der Vusse GJ, Wijnen RM, et al. University of Wisconsin solution is superior to histidine tryptophan ketoglutarate for preservation of ischemically damaged kidneys. Transplantation 1994; 58: 979.
23. Groenewoud AF, de Boer J. A report of the eurotransplant randomized multicenter study comparing kidney graft preservation with HTK, UW and EC solutions. HTK study group. Transpl Int 1994; 7(suppl 1): S479.
24. Gebhard MM, Preusse CJ, Schnabel PA, et al. Different effects of cardioplegic solution HTK during single or intermittent administration. Thorac Cardiovasc Surg 1984; 32: 271.
25. Tojimbara T, Wicomb WN, Garcia-Kennedy R, et al. Liver transplantation from non-heart beating donors in rats: Influence of viscosity and temperature of initial flushing solutions on graft function. Liver Transpl Surg 1997; 3: 39.
26. Pirenne J, Van Gelder F, Coosemans W, et al. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation. Liver Transpl 2001; 7: 540.
27. Cavallari A, Cillo U, Nardo B, et al. A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation. Liver Transpl 2003; 9: 814.
28. Balupuri S, Buckley P, Snowden C, et al. The trouble with kidneys derived from the non heart-beating donor: A single center 10-year experience. Transplantation 2000; 69: 842.
29. Song SB, Ahmed I, Attia MS, et al. Comparison of the protective effects of phosphate-buffered sucrose and University of Wisconsin solution in a non-heart-beating liver donor experiment. Transplant Proc 2001; 33: 884.